Peptide guide
GLOW: what it is and what the research actually shows
GLOW is a name used for one vial that mixes three peptides: GHK-Cu, BPC-157 and TB-500. It is not one peptide, and no published study has tested the three together. Some clinics use the same word for an unrelated skin drip.
Byline: Mark Sommers, editor. Sources checked 08-22-2026. Every claim below links to its PubMed record or FDA page.
Quick facts
- What is in it
- GHK-Cu
- BPC-157
- TB-500 (thymosin beta-4 fragment)
One vial sold under this name mixes the three peptides above. We did not test any vial, so we cannot say what a given one contains.
- Studied for
- Skin and wound repair (GHK-Cu, TB-500), gut and tendon healing (BPC-157). Almost all of it in cells or animals.
- Studies of the blend itself
- None. A PubMed search on 08-22-2026 for the three peptides together found only two general reviews that discuss them one at a time, and no study that gave them together.
- Human evidence, part by part
- GHK-CuLimited3 human studies foundBPC-157Limited3 human studies foundTB-500 (thymosin beta-4 fragment)Limited2 human studies found
- Approved by the FDA?
- No. See where it stands.
Benefits
- Evidence Eased discomfort and surface damage in severe dry eye, in a 9-person trial of TB-500's parent protein as eye drops. PMID 25826322
- Evidence Sped healing of burn wounds in mice given liposome-packaged GHK-Cu. PMID 28370978
- Evidence Reduced flaking on the scalp after 15 days, in a 29-person open-label trial of a GHK-Cu serum. PMID 39449909
- Evidence Improved healing of tendon, ligament, muscle and bone across 35 animal studies of BPC-157. PMID 40756949
- Suggested Discussed for skin and wound repair and for gut and tendon healing, per the blend's marketed uses.
- Suggested Promoted as a combined healing-and-skin protocol, though no study has ever tested these three peptides together.
- Suggested Discussed by online clinician commentary as pairing the 'Wolverine' repair duo with GHK-Cu's tissue remodeling.
Evidence items link to the study behind them. Suggested items are claims in circulation, not results.
Reported side effects
- No human safety data exists for injected GHK-Cu; all human testing used creams or serums on skin.
- A 2025 review found no clinical safety data exist for BPC-157, which is banned by anti-doping regulators. PMID 40005999
- No biomarker changes appeared in a two-person pilot checking heart, liver, kidney, thyroid and blood sugar after BPC-157. PMID 40131143
- Eye drops made from TB-500's full parent protein were safe over 56 days in a 9-person trial. PMID 25826322
- All three peptides in this blend are FDA substances nominated for compounding, then withdrawn over safety concerns.
Safety, before anything else
None of these is an approved medicine. Every part of this blend is on the FDA list of substances that were nominated for compounding and then withdrawn. For most of them the human safety record is a handful of people, and for at least one of them it is nobody at all. Here is every safety signal we found in the studies, before you read anything about what they might do.
GHK-Cu
- No skin reactions flagged in the one small trial (a cream). PMID 16847171
- No adverse events over 15 days of a scalp product. PMID 39449909
- We found no published human safety data for injected GHK-Cu; all human data is topical.
BPC-157
- Animal studies show no harm across organs; no human safety data. PMID 40756949
- Placed on the World Anti-Doping Agency prohibited list in 2022; unapproved by regulators. PMID 40005999
- No biomarker changes in a two-person pilot. PMID 40131143
TB-500 (thymosin beta-4 fragment)
- Eye drops safe and well tolerated over 56 days in a 9-person trial. PMID 25826322
- We found no human study of the shorter TB-500 fragment that is actually sold.
We do not publish amounts or schedules of our own, on any page. The clinician commentary lower on this page quotes amounts that named clinicians state on camera, labeled and linked to the source video. Those are their words, not our guidance. Why we draw that line.
How to read the grades
Each study gets a tag. Cells in a dish means it never touched a living animal. Animals means mice or rats, usually. Small human study means a handful of people with no comparison group. Human trial means people were randomly split into treated and untreated groups, which is the only kind that can show an effect is real. Review and Systematic review sum up other studies. The full rule is on How we check.
GHK-Cu
A small natural peptide (three amino acids) that binds copper. Found in human blood; levels fall with age. Studied mostly for skin and tissue repair.
Human evidence: Limited. 3 human studies found in our search.
What has been studied
| Who or what was studied | What was found, and the catch | Source |
|---|---|---|
| Review | Reviews evidence that GHK-Cu changes the activity of many genes tied to repair and inflammation. Limit: Written by the peptide's discoverer; gene correlations, not patient outcomes. | Pickart 2018 PMID 29986520 |
| Animals | GHK-Cu packed into liposomes sped healing of scald burns in mice. Limit: Burn model, and a special delivery form rather than plain GHK-Cu. | Wang 2017 PMID 28370978 |
| Small human study n = 20 (blood levels only) | People with COPD had lower blood GHK; in mice, GHK-Cu reduced smoke-related muscle loss. Limit: The human part only measured blood levels; the treatment effect is in mice. | Deng 2023 PMID 36905132 |
| Human trial n = 13 people | After laser skin resurfacing, a copper-peptide cream did not beat control on measured redness or wrinkles; patients did report liking it more. Limit: Thirteen people, a cream, one subjective win. | Miller 2006 PMID 16847171 |
| Small human study n = 29 people | A scalp routine with a copper-peptide serum plus a scrub reduced flaking over 15 days. Limit: No control group, company-employed authors, peptide mixed with other actives. | Patel 2024 PMID 39449909 |
Safety signals in the studies
- No skin reactions flagged in the one small trial (a cream). PMID 16847171
- No adverse events over 15 days of a scalp product. PMID 39449909
- We found no published human safety data for injected GHK-Cu; all human data is topical.
BPC-157
A lab-made peptide (15 amino acids) copied from a piece of a protein in human stomach fluid. Studied mostly in rats for gut and tendon healing.
Human evidence: Limited. 3 human studies found in our search.
What has been studied
| Who or what was studied | What was found, and the catch | Source |
|---|---|---|
| Systematic review n = 36 studies, 1 human | Of 36 studies, 35 were in animals, where healing of tendon, ligament, muscle and bone improved. The one human study was small and retrospective. Limit: Review says plainly: no clinical safety data exist for BPC-157. | Vasireddi 2025 PMID 40756949 |
| Animals | Rat tendon cells in a dish grew out and moved more with BPC-157. Limit: Cells only. | Chang 2011 PMID 21030672 |
| Small human study n = 16 people | Patients given BPC-157 for knee pain mostly said they felt better when phoned months later. Limit: No control group, no imaging, relies on memory by phone. | Lee 2021 PMID 34324435 |
| Small human study n = 12 people | Women with stubborn bladder pain reported big improvements after BPC-157. Limit: Twelve people, one clinic, no comparison group. | Lee 2024 PMID 39325560 |
| Small human study n = 2 people | Two adults showed no change in heart, liver, kidney, thyroid or sugar markers after BPC-157. Limit: Two people. Far too few to call anything safe. | Lee 2025 PMID 40131143 |
| Review | Broad activity in animal injury models, but not approved for human use anywhere for lack of clinical data. Limit: Narrative and patent review. | Józwiak 2025 PMID 40005999 |
Safety signals in the studies
- Animal studies show no harm across organs; no human safety data. PMID 40756949
- Placed on the World Anti-Doping Agency prohibited list in 2022; unapproved by regulators. PMID 40005999
- No biomarker changes in a two-person pilot. PMID 40131143
Most cited author in this list: Lee, 3 of 6 sources. When a small number of groups produce most of the evidence, independent replication is thinner than the source count suggests.
TB-500 (thymosin beta-4 fragment)
Thymosin beta-4 is a natural protein in almost every cell that helps cells move and rebuild. TB-500 is the name used for a lab-made piece of it. Most studies used the full protein, not the fragment.
Human evidence: Limited. 2 human studies found in our search.
What has been studied
| Who or what was studied | What was found, and the catch | Source |
|---|---|---|
| Human trial n = 9 people | Thymosin beta-4 eye drops eased discomfort and surface damage in severe dry eye versus placebo. Limit: Nine people, eye drops, many comparisons. | Sosne 2015 PMID 25826322 |
| Human trial n = 96 people | In a 96-patient heart-attack trial, the main result was not statistically significant; a timing subgroup showed smaller infarcts. Mice showed less heart damage. Limit: Used the full recombinant protein, not the TB-500 fragment sold. | Zhang 2025 PMID 41229390 |
| Review | Summarizes thymosin beta-4's role in cell movement and tissue repair and lists trials then under way. Limit: Author helped develop the compound. | Goldstein 2012 PMID 22074294 |
| Review | Says phase 2 wound trials found faster repair and good tolerability. Limit: Cites the authors' own work; trial reports not separately checked here. | Kleinman 2016 PMID 27450738 |
| Review | How thymosin beta-4 was found as the cell's main actin-binding peptide. Limit: Basic science, not treatment. | Hannappel 2007 PMID 17468232 |
Safety signals in the studies
- Eye drops safe and well tolerated over 56 days in a 9-person trial. PMID 25826322
- We found no human study of the shorter TB-500 fragment that is actually sold.
Where it stands with regulators
- All three peptides appear on the FDA's list of bulk drug substances nominated for compounding and then withdrawn, over possible immune reactions and peptide-related impurities. None is an FDA-approved drug. Page last updated 04-22-2026. Source
- A 2025 review states BPC-157 is not approved by the FDA or any other regulator for lack of clinical data, and was put on the World Anti-Doping Agency prohibited list in 2022. Source
What is missing
No study of the blend itself. No large human trial of any part in the form that is sold. No long-term safety data in people for any part. Where this page says "limited," read it as "a few small studies that cannot settle the question."
Clinician commentary (YouTube)
This is commentary, not evidence. 3 clinicians with large audiences discuss this on camera. Each video below is summarized in our words and linked so you can watch the source yourself. Any amounts mentioned are what the named clinician says on camera, not PeptideGauge guidance. The graded studies above remain the record of what is known. How this layer works.
Dr. Alex Tatem
In “GHK-Cu: The Peptide Everyone Is Injecting (Big Mistake?)”, Dr. Alex Tatem discusses GLOW. What he says, in short:
- He says the most consistently reported anecdotal benefit is improved skin texture, firmness, elasticity, and glow, mainly from Reddit and peptide forum users.
- He describes the copper uglies, where some users' skin looks temporarily worse, more wrinkled or sagging, after starting GHK-Cu, especially at higher doses.
- He says the likely mechanism is that GHK-Cu can rev up collagen-degrading MMP enzymes faster than new collagen gets built, and that most people who experience this recover within two to four weeks of stopping.
- He says hair results are more mixed, with some users reporting thicker hair over three to six months and others reporting nothing, and cautions there are no large randomized trials for hair growth yet.
- He says if someone is using a well-formulated topical copper peptide serum for skin, the published science genuinely supports it working.
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Alex Tatem’s, not ours.
In “The Truth About Popular Peptides (What Works, What’s Overhyped) | Peptide Tier List pt.1”, Dr. Alex Tatem discusses GLOW. What he says, in short:
- He describes the Glow stack as combining BPC-157, TB-500, and GHK-Cu into one injection to cover healing, collagen, and anti-inflammatory effects at once.
- He says there are people who absolutely swear by the stack.
- He argues the stack is built from compounds that individually only have so-so supporting data, and a stack is only as strong as its weakest link.
- He gives the Glow stack a C tier rating overall.
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Alex Tatem’s, not ours.
1 more video where Dr. Alex Tatem covers GLOW
In “Every Popular Peptide Ranked | GLP-1, Growth Hormone, HCG, NAD+, IGF-1, Peptide Tier List”, Dr. Alex Tatem discusses GLOW. What he says, in short:
- He defines the Glow Stack as BPC-157, TB-500, and GHK-Cu combined into a single injection meant to cover healing, collagen, and anti-inflammatory effects at once.
- He says a stack is only as strong as its weakest link, and since it's built from compounds with so-so individual data, he gives the Glow Stack a C tier ranking despite people swearing by it.
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Alex Tatem’s, not ours.
Dr. Ashley Froese
In “Every Peptide Side Effect Explained (What 25+ Compounds Actually Do To Your Body)”, Dr. Ashley Froese discusses GLOW. What she says, in short:
- She groups BPC-157, TB-500, and GHK copper together as the peptides in the Glow stack, used a lot for healing and tissue repair.
- For BPC-157 within the stack, she says side effects seem rare, but some people report head pressure, GI effects, and anhedonia, which she links to its effects on nitric oxide and on dopamine and serotonin pathways.
- For TB-500, paired with BPC-157 in the Wolverine stack, she says to watch for facial flushing, head pressure, or sudden fatigue right after dosing.
- She says both BPC-157 and TB-500 carry a theoretical, unproven concern about encouraging tumor growth because of the new blood vessel formation they promote.
- For GHK copper, she says it sounds incredible on paper for gene signaling toward repair, lowering inflammation, collagen remodeling, and hair follicle regeneration, but that injecting it can feel like liquid fire, with intense burning, redness, and hard lump like knots under the skin for some people.
- She warns that using GHK copper without balancing it with zinc can lead to copper toxicity, causing a metallic taste, severe headaches, and mood swings.
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Ashley Froese’s, not ours.
In “KLOW - Dr Explains The Peptide Stack For Healing, Inflammation and Regeneration”, Dr. Ashley Froese discusses GLOW. What she says, in short:
- She says the Glow stack is the Wolverine stack, BPC-157 and TB-500, with GHK-copper added.
- She explains the logic as BPC-157 supplying blood flow, TB-500 mobilizing cell migration, and GHK-copper remodeling tissue structure, hitting what she calls a supply, mobilize, remodel trifecta.
- She flags copper toxicity as an uncommon but real risk that comes with adding GHK-copper into this combination.
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Ashley Froese’s, not ours.
1 more video where Dr. Ashley Froese covers GLOW
In “Real Doctor: If I Started Peptides Today, I'd Do THIS (The Ultimate Peptide Roadmap)”, Dr. Ashley Froese discusses GLOW. What she says, in short:
- She defines the glow stack as BPC 157, TB 500, and GHK copper used together.
- She positions it as the step after basic repair, aimed at skin, hair, and wound healing alongside tissue repair.
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Ashley Froese’s, not ours.
Dr. Jones, DC
In “Doctor Reacts to Most Powerful Peptide Stacks (GLOW, KLOW & Wolverine)”, Dr. Jones, DC discusses GLOW. What he says, in short:
- He defines GLOW as GHK-Cu plus BPC-157 plus TB-500 and calls it the anti-aging and healing stack aimed at skin, collagen, and tissue repair.
- He describes a clinic range of around 2 milligrams of GHK-Cu with about 500 micrograms each of BPC-157 and TB-500 daily, calling these common practitioner ranges that are always individualized.
- He says the women in their late 40s and 50s who come to his clinic for it typically notice skin texture changes around week four to six and describe more bounce back and reduced fine lines, which he presents as clinic observation.
- He says people quit at two weeks expecting instant results and that collagen remodeling takes longer, with hair regrowth taking at least six to eight weeks.
- He says GHK-Cu is the most common cause of injection site welts and stinging in the stack, and that increasing the dilution to four or five milliliters can help.
- He says reconstitution math is where people go wrong most often, ending up ten times too high or ten times too low without knowing it.
Glow is GHK copper plus BPC157 plus TB500.
We typically work with glow dosing protocols around 2 milligs or so of GHK copper with about 500 micrograms of BPC-157 and TB500 daily.
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.
In “This Peptide Stack Prevents or Fixes Ozempic Face Fast! (Doctor Explains)”, Dr. Jones, DC discusses GLOW. What he says, in short:
- He defines GLOW as GHK-Cu, BPC-157, and TB-500, and insists the other two are not fillers hanging off the copper peptide.
- He says GHK-Cu is the signal telling skin to rebuild collagen and elastin, and that BPC-157 and TB-500 exist to get the tissue into a state where that signal actually lands.
- He says this is why GHK-Cu alone underdelivers for so many people running it solo for facial volume loss.
- He labels the synergy as logic rather than proof, calling it the thinking behind the stack and what he sees hold up with the patients he works with.
- He says the stack only solves the surface half of the problem and does nothing for the muscle and structural half underneath.
- He says protein targets, resistance training, and a slower rate of weight loss are the load bearing parts people skip because they are harder to sell than a vial.
- He says anyone promising a peptide will refill a face within a week is selling something.
The peptide stack here is Glow. Three peptides: GHK copper, BPC-157, TB-500.
They're sending a rebuild signal into tissue that isn't in any condition to rebuild.
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.
1 more video where Dr. Jones, DC covers GLOW
In “Doctor Explains GHK-Cu the Glow & Grow Peptide”, Dr. Jones, DC discusses GLOW. What he says, in short:
- He says the GLOW stack people chase is really three peptides, GHK-Cu, BPC-157, and TB-500, and that this part is not the confusing bit.
- He says the copper peptide is the one whose delivery route decides what the whole stack delivers.
- He says the glow itself comes from the copper peptide and that taking it out of the stack takes the glow with it.
- He says BPC-157 and TB-500 are quietly handling gut and joints in the background rather than skin.
- He says neither of the other two signals collagen and elastin, regrows hair, or runs the broad genetic repair program he attributes to GHK-Cu.
- He says whether the full stack earns its cost depends on whether the goal is surface skin or deep systemic repair.
when people say the glow peptide, the glow is coming from the copper one
Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.
Common questions
Is GLOW one peptide?
No. It is a market name for a mix of three peptides in one vial. Each one has its own research; the mix has none.
Is GLOW the same as the GLOW skin drip some clinics offer?
No. That one is GHK-Cu with glutathione and vitamin C. Same word, different product. Check the label.
Has GLOW been tested in people?
Not as a blend. The three parts have a handful of small human studies, mostly skin creams, eye drops, or the full thymosin protein rather than what is sold.
Is it FDA approved?
No. All three peptides are on the FDA's list of compounding substances that were nominated and withdrawn over safety questions.
Will this page tell me how much to use?
No. We do not publish amounts or schedules for any peptide. That belongs with a licensed doctor.
Sources
- Chang (2011). PMID 21030672
- Deng (2023). PMID 36905132
- Goldstein (2012). PMID 22074294
- Hannappel (2007). PMID 17468232
- Józwiak (2025). PMID 40005999
- Kleinman (2016). PMID 27450738
- Lee (2021). PMID 34324435
- Lee (2024). PMID 39325560
- Lee (2025). PMID 40131143
- Miller (2006). PMID 16847171
- Patel (2024). PMID 39449909
- Pickart (2018). PMID 29986520
- Sosne (2015). PMID 25826322
- Vasireddi (2025). PMID 40756949
- Wang (2017). PMID 28370978
- Zhang (2025). PMID 41229390
FDA list of bulk drug substances nominated for compounding and withdrawn, last updated 04-22-2026: fda.gov.
Want these studies next to every other one on the site?
Open the evidence tableMixing a vial? Do the math with the calculator.
Open the calculator